Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.

MLA

Baumgardt, Shelley L., et al. “Genetic Deletion or Pharmacologic Inhibition of Histone Deacetylase 6 Protects the Heart against Ischaemia/Reperfusion Injury by Limiting Tumour Necrosis Factor Alpha-Induced Mitochondrial Injury in Experimental Diabetes.” Cardiovascular Research, vol. 120, no. 12, Oct. 2024, pp. 1456–71. EBSCOhost, https://doi.org/10.1093/cvr/cvae144.

APA

Baumgardt, S. L., Fang, J., Fu, X., Liu, Y., Xia, Z., Zhao, M., Chen, L., Mishra, R., Gunasekaran, M., Saha, P., Forbess, J. M., Bosnjak, Z. J., Camara, A. K. S., Kersten, J. R., Thorp, E. B., Kaushal, S., & Ge, Z.-D. (2024). Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes. Cardiovascular Research, 120(12), 1456–1471. https://doi.org/10.1093/cvr/cvae144

Chicago

Baumgardt, Shelley L, Juan Fang, Xuebin Fu, Yanan Liu, Zhengyuan Xia, Ming Zhao, Ling Chen, et al. 2024. “Genetic Deletion or Pharmacologic Inhibition of Histone Deacetylase 6 Protects the Heart against Ischaemia/Reperfusion Injury by Limiting Tumour Necrosis Factor Alpha-Induced Mitochondrial Injury in Experimental Diabetes.” Cardiovascular Research 120 (12): 1456–71. doi:10.1093/cvr/cvae144.